BIO-RAD LABORATORIES, INC. financial data

Symbol
BIO, BIO-B on NYSE
Location
Hercules, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 29 Oct 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 573% % -7.5%
Quick Ratio 153% % -4.7%
Debt-to-equity 43% % 5.1%
Return On Assets -7% % -1.2%
Operating Margin 9% % -26%

Shares

Label TTM Value / Value Unit Change %
Weighted Average Number of Shares Outstanding, Basic 26,923,000 shares -3.7%
Weighted Average Number of Shares Outstanding, Diluted 26,923,000 shares -3.8%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $2,557,500,000 USD -0.88%
Research and Development Expense $284,900,000 USD 1.7%
Operating Income (Loss) $224,500,000 USD -27%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $842,600,000 USD 16%
Income Tax Expense (Benefit) $166,700,000 USD 26%
Net Income (Loss) Attributable to Parent $675,900,000 USD 13%
Earnings Per Share, Basic -24 USD/shares 11%
Earnings Per Share, Diluted -24 USD/shares 11%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $395,800,000 USD -3.6%
Accounts Receivable, after Allowance for Credit Loss, Current $464,700,000 USD 0.6%
Inventory, Net $783,200,000 USD -2.6%
Other Assets, Current $23,500,000 USD -17%
Assets, Current $2,842,000,000 USD -7%
Property, Plant and Equipment, Net $528,100,000 USD -0.17%
Operating Lease, Right-of-Use Asset $180,300,000 USD 3.7%
Intangible Assets, Net (Excluding Goodwill) $388,400,000 USD 26%
Goodwill $578,700,000 USD 39%
Other Assets, Noncurrent $101,900,000 USD 7.4%
Assets $9,696,400,000 USD -8.6%
Accounts Payable, Current $128,800,000 USD 5.4%
Employee-related Liabilities, Current $182,800,000 USD 25%
Liabilities, Current $522,300,000 USD 4.9%
Long-term Debt and Lease Obligation $1,200,400,000 USD 0.11%
Deferred Income Tax Liabilities, Net $872,600,000 USD -19%
Operating Lease, Liability, Noncurrent $155,800,000 USD 8.3%
Other Liabilities, Noncurrent $207,500,000 USD 5%
Liabilities $2,959,600,000 USD -5%
Accumulated Other Comprehensive Income (Loss), Net of Tax $166,800,000 USD 47%
Retained Earnings (Accumulated Deficit) $7,456,300,000 USD -8.3%
Stockholders' Equity Attributable to Parent $6,736,800,000 USD -10%
Liabilities and Equity $9,696,400,000 USD -8.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $129,900,000 USD 86%
Net Cash Provided by (Used in) Financing Activities $97,700,000 USD
Net Cash Provided by (Used in) Investing Activities $2,900,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $33,300,000 USD 13%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $398,200,000 USD -3.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities $22,200,000 USD -0.89%
Deferred Tax Assets, Valuation Allowance $95,200,000 USD 79%
Deferred Tax Assets, Gross $251,000,000 USD -4.9%
Operating Lease, Liability $192,600,000 USD 3.2%
Payments to Acquire Property, Plant, and Equipment $34,400,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid $230,700,000 USD 8.7%
Property, Plant and Equipment, Gross $1,637,300,000 USD 2.6%
Operating Lease, Liability, Current $36,800,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Two $35,200,000 USD -5.6%
Lessee, Operating Lease, Liability, to be Paid, Year One $42,700,000 USD -13%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 25%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $38,100,000 USD 49%
Lessee, Operating Lease, Liability, to be Paid, Year Three $27,400,000 USD -4.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 7,500,000 shares 0%
Unrecognized Tax Benefits $88,500,000 USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $22,800,000 USD 2.7%
Operating Lease, Payments $44,600,000 USD 4%
Additional Paid in Capital $461,900,000 USD 3%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $22,600,000 USD 3.7%
Deferred Tax Assets, Net of Valuation Allowance $155,800,000 USD -26%
Interest Expense $49,100,000 USD 0.16%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%